Related references
Note: Only part of the references are listed.Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia
Ali Ovayolu et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)
Increased Carotid Intima-Media Thickness and Endothelial Cell-Specific Molecule-1 (Endocan) Levels in Obese Children
Aysin Nalbantoglu et al.
ANGIOLOGY (2021)
Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes
Aleksandra Klisic et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The Relationship Between Serum Endocan Levels With the Presence of Slow Coronary Flow: A Cross-Sectional Study
Harun Kundi et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2017)
Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea
Nejat Altintas et al.
ANGIOLOGY (2016)
Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes: A Preliminary Study
Yucel Arman et al.
ANGIOLOGY (2016)
Endocan: a new biomarker associated with inflammation in type 2 diabetes mellitus?
Kathryna F. Rodrigues et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension
Xiang-sheng Wang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study
Murat Kose et al.
ANGIOLOGY (2015)
Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes
Henry Adekola et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2015)
Endocan-A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study
Sevket Balta et al.
ANGIOLOGY (2014)
Serum endocan levels as a marker of disease activity in patients with Behcet disease
Ilknur Balta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease
Mahmut I. Yilmaz et al.
KIDNEY INTERNATIONAL (2014)
Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease
I. Balta et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The Comparative Effects of Valsartan and Amlodipine on Vascular Microinflammation in Newly Diagnosed Hypertensive Patients
Murat Unlu et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2013)
The Comparative Effects of Valsartan and Amlodipine on vWf Levels and N/L Ratio in Patients with Newly Diagnosed Hypertension
Murat Karaman et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2013)
The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)
S. G. Lakoski et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Normative Values and Correlates of Mean Common Carotid Intima-Media Thickness in the Korean Rural Middle-aged Population: The Atherosclerosis Risk of Rural Areas iN Korea General Population (ARIRANG) Study
Young Jin Youn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
The levels of the leptin and adiponectin according to body mass index and their relationship with oxidative parameters
Nihat Soylemez et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2010)
Identification and functional analysis of endothelial tip cell-enriched genes
Raquel del Toro et al.
BLOOD (2010)
Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan
Stephane Sarrazin et al.
GLYCOBIOLOGY (2010)
The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences
Sarah de Ferranti et al.
CLINICAL CHEMISTRY (2008)
Childhood obesity and its relation to serum adiponectin and leptin: A report from a population-based study
Rimei Nishimura et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Metabolic complications of obesity: inflated or inflamed?
Manisha Chandalia et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2007)
Serum markers of vascular inflammation in dyslipemia
Gemma Francisco et al.
CLINICA CHIMICA ACTA (2006)
Endothelial dysfunction and arterial abnormalities in childhood obesity
M. R. Skilton et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women
J Lo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy
S Sarrazin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
Association between circulating adiponectin and interleukin-10 levels in android obesity:: Effects of weight loss
MR Manigrasso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mechanisms of endothelial dysfunction in obesity
A Avogaro et al.
CLINICA CHIMICA ACTA (2005)
Early activation of vascular endothelial cells and platelets in obese children
G Desideri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study
DS Freedman et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Adiponectin and atherosclerotic disease
K Shimada et al.
CLINICA CHIMICA ACTA (2004)
Adipose tissue as an endocrine organ
EE Kershaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The clinical implications of endothelial dysfunction
ME Widlansky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
The metabolic syndrome - Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
YW Park et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1
D Béchard et al.
JOURNAL OF IMMUNOLOGY (2001)
Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies
D Bechard et al.
JOURNAL OF VASCULAR RESEARCH (2000)
Circulating adhesion molecules and severity of coronary atherosclerosis
Y Oishi et al.
CORONARY ARTERY DISEASE (2000)
Flow-mediated vasoactivity and circulating adhesion molecules in hypertreglyceridemia: Association with small, dense LDL cholesterol particles
G Lupattelli et al.
AMERICAN HEART JOURNAL (2000)